Recent advances and future challenges in gene therapy for hearing loss
Hearing loss is the most common sensory deficit experienced by humans and represents one of the largest chronic health conditions worldwide. It is expected that around 10% of the world's population will be affected by disabling hearing impairment by 2050. Hereditary hearing loss accounts for mo...
Main Authors: | Ana E. Amariutei, Jing-Yi Jeng, Saaid Safieddine, Walter Marcotti |
---|---|
Format: | Article |
Language: | English |
Published: |
The Royal Society
2023-06-01
|
Series: | Royal Society Open Science |
Subjects: | |
Online Access: | https://royalsocietypublishing.org/doi/10.1098/rsos.230644 |
Similar Items
-
Using Drosophila to study mechanisms of hereditary hearing loss
by: Tongchao Li, et al.
Published: (2018-06-01) -
Hearing loss: The final frontier of pharmacology
by: Alan C. Foster, et al.
Published: (2022-06-01) -
Future Pharmacotherapy for Sensorineural Hearing Loss by Protection and Regeneration of Auditory Hair Cells
by: Mami Matsunaga, et al.
Published: (2023-02-01) -
Cochlear hearing loss : physiological, psychological and technical issues /
by: 443978 Moore, Brian C. J.
Published: (2007) -
Rapamycin Added to Diet in Late Mid-Life Delays Age-Related Hearing Loss in UMHET4 Mice
by: Richard A. Altschuler, et al.
Published: (2021-04-01)